Literature DB >> 22673584

Radiological evaluation by magnetic resonance of the 'new anatomy' of transsexual patients undergoing male to female sex reassignment surgery.

E Brunocilla1, M Soli, A Franceschelli, R Schiavina, M Borghesi, G Gentile, C V Pultrone, G Martorana, M G Orrei, F Colombo.   

Abstract

Magnetic resonance (MR) is the best way to assess the new anatomy of the pelvis after male to female (MtF) sex reassignment surgery. The aim of the study was to evaluate the radiological appearance of the small pelvis after MtF surgery and to compare it with the normal women's anatomy. Fifteen patients who underwent MtF surgery were subjected to pelvic MR at least 6 months after surgery. The anthropometric parameters of the small pelvis were measured and compared with those of ten healthy women (control group). Our personal technique (creation of the mons Veneris under the pubic skin) was performed in all patients. In patients who underwent MtF surgery, the mean neovaginal depth was slightly superior than in women (P=0.009). The length of the inferior pelvic aperture and of the inlet of pelvis was higher in the control group (P<0.005). The inclination between the axis of the neovagina and the inferior pelvis aperture, the thickness of the mons Veneris and the thickness of the rectovaginal septum were comparable between the two study groups. MR consents a detailed assessment of the new pelvic anatomy after MtF surgery. The anthropometric parameters measured in our patients were comparable with those of women.

Entities:  

Mesh:

Year:  2012        PMID: 22673584     DOI: 10.1038/ijir.2012.18

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  1 in total

1.  MR imaging in patients with male-to-female sex reassignment surgery: postoperative anatomy and complications.

Authors:  Michele Bertolotto; Giovanni Liguori; Stefano Bucci; Mariano Iannelli; Francesca Vedovo; Nicola Pavan; Carlo Trombetta; Lorenzo E Derchi
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.